As the furor over soaring U.S. prescription drug prices escalates and outrageous price hikes by several smaller drugmakers give the entire industry a black eye, the biggest U.S.-based drugmaker is expanding financial assistance to patients. Pfizer Inc. says it’s doubling its income limit for people to receive dozens of its medicines without a copayment because more patients need help.